10-Q 1 vff-10q_20220331.htm 10-Q vff-10q_20220331.htm
false Q1 0001584549 --12-31 2023-06-30 2024-02-29 2024-02-29 P6Y3M18D P3M18D P7Y10M20D P9Y10M2D P1Y3M3D P9Y7M20D P7Y14D 0001584549 2022-01-01 2022-03-31 xbrli:shares 0001584549 2022-05-06 iso4217:USD 0001584549 2022-03-31 0001584549 2021-12-31 iso4217:USD xbrli:shares 0001584549 2021-01-01 2021-03-31 0001584549 us-gaap:CommonStockMember 2021-12-31 0001584549 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001584549 us-gaap:RetainedEarningsMember 2021-12-31 0001584549 us-gaap:NoncontrollingInterestMember 2021-12-31 0001584549 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001584549 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001584549 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001584549 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001584549 us-gaap:CommonStockMember 2022-03-31 0001584549 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001584549 us-gaap:RetainedEarningsMember 2022-03-31 0001584549 us-gaap:NoncontrollingInterestMember 2022-03-31 0001584549 us-gaap:CommonStockMember 2020-12-31 0001584549 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001584549 us-gaap:RetainedEarningsMember 2020-12-31 0001584549 2020-12-31 0001584549 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001584549 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001584549 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001584549 us-gaap:CommonStockMember 2021-03-31 0001584549 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001584549 us-gaap:RetainedEarningsMember 2021-03-31 0001584549 2021-03-31 0001584549 vff:RoseAcquisitionMember 2022-01-01 2022-03-31 xbrli:pure 0001584549 vff:RoseLifeScienceIncMember 2022-03-31 0001584549 us-gaap:PublicUtilitiesInventoryRawMaterialsMember vff:CannabisBusinessMember 2022-03-31 0001584549 us-gaap:PublicUtilitiesInventoryRawMaterialsMember vff:CannabisBusinessMember 2021-12-31 0001584549 vff:PublicUtilitiesInventoryWorkInProgressMember vff:CannabisBusinessMember 2022-03-31 0001584549 vff:PublicUtilitiesInventoryWorkInProgressMember vff:CannabisBusinessMember 2021-12-31 0001584549 vff:PublicUtilitiesInventoryFinishedGoodsMember vff:CannabisBusinessMember 2022-03-31 0001584549 vff:PublicUtilitiesInventoryFinishedGoodsMember vff:CannabisBusinessMember 2021-12-31 0001584549 vff:PublicUtilitiesInventoryPackagingMember vff:CannabisBusinessMember 2022-03-31 0001584549 vff:PublicUtilitiesInventoryPackagingMember vff:CannabisBusinessMember 2021-12-31 0001584549 vff:CropInventoryMember vff:ProduceAndEnergyMember 2022-03-31 0001584549 vff:CropInventoryMember vff:ProduceAndEnergyMember 2021-12-31 0001584549 vff:PurchasedProduceMember vff:ProduceAndEnergyMember 2022-03-31 0001584549 vff:PurchasedProduceMember vff:ProduceAndEnergyMember 2021-12-31 0001584549 vff:SparePartsInventoryAndPackagingMember vff:ProduceAndEnergyMember 2022-03-31 0001584549 vff:SparePartsInventoryAndPackagingMember vff:ProduceAndEnergyMember 2021-12-31 0001584549 us-gaap:LandMember 2022-03-31 0001584549 us-gaap:LandMember 2021-03-31 0001584549 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2022-03-31 0001584549 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2021-03-31 0001584549 us-gaap:BuildingMember 2022-03-31 0001584549 us-gaap:BuildingMember 2021-03-31 0001584549 us-gaap:MachineryAndEquipmentMember 2022-03-31 0001584549 us-gaap:MachineryAndEquipmentMember 2021-03-31 0001584549 us-gaap:ConstructionInProgressMember 2022-03-31 0001584549 us-gaap:ConstructionInProgressMember 2021-03-31 0001584549 vff:CannabisBusinessMember country:CA 2021-12-31 0001584549 vff:CannabisBusinessMember country:US 2021-12-31 0001584549 vff:CannabisBusinessMember country:CA 2022-01-01 2022-03-31 0001584549 vff:CannabisBusinessMember country:CA 2022-03-31 0001584549 vff:CannabisBusinessMember country:US 2022-03-31 0001584549 us-gaap:LicensingAgreementsMember 2022-03-31 0001584549 us-gaap:LicensingAgreementsMember 2021-12-31 0001584549 vff:BrandAndTrademarksMember 2022-03-31 0001584549 vff:BrandAndTrademarksMember 2021-12-31 0001584549 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-03-31 0001584549 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-12-31 0001584549 us-gaap:OtherIntangibleAssetsMember 2022-03-31 0001584549 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0001584549 vff:OperatingLeasesMember 2022-03-31 0001584549 vff:RoseAcquisitionMember 2021-11-15 2021-11-15 0001584549 vff:RoseAcquisitionMember 2021-11-15 iso4217:CAD 0001584549 us-gaap:CommonStockMember vff:RoseAcquisitionMember 2021-11-15 0001584549 vff:ManagementShareholdersMember vff:RoseAcquisitionMember 2021-11-15 vff:CoFounder 0001584549 us-gaap:CallOptionMember vff:RoseAcquisitionMember 2021-11-15 0001584549 vff:AltumInternationalPvtLtdMember 2021-12-31 0001584549 vff:LeliHollandBVMember vff:OptionAgreementMember 2021-09-01 2021-09-30 iso4217:EUR 0001584549 vff:LeliHollandBVMember vff:OptionAgreementMember 2021-09-30 0001584549 vff:LLLichtendahlBeheerBVMember 2022-03-18 0001584549 vff:LLLichtendahlBeheerBVMember 2022-03-18 2022-03-18 0001584549 vff:VillageFieldsHempUSALLCMember 2022-03-31 0001584549 vff:VillageFieldsHempUSALLCMember 2021-12-31 0001584549 vff:VillageFieldsHempUSALLCMember 2022-01-01 2022-03-31 0001584549 vff:VillageFieldsHempUSALLCMember 2021-01-01 2021-03-31 0001584549 vff:TermLoanFCCLoanMember 2022-01-01 2022-03-31 0001584549 vff:TermLoanFCCLoanMember 2021-01-01 2021-12-31 0001584549 vff:TermLoanVFCEMember 2021-01-01 2021-12-31 0001584549 vff:TermLoanOneMember vff:PureSunfarmsMember 2022-01-01 2022-03-31 0001584549 vff:TermLoanOneMember vff:PureSunfarmsMember 2021-01-01 2021-12-31 0001584549 vff:TermLoanTwoMember vff:PureSunfarmsMember 2022-01-01 2022-03-31 0001584549 vff:TermLoanTwoMember vff:PureSunfarmsMember 2021-01-01 2021-12-31 0001584549 vff:BDCFacilityMember vff:PureSunfarmsMember 2022-01-01 2022-03-31 0001584549 vff:BDCFacilityMember vff:PureSunfarmsMember 2021-01-01 2021-12-31 0001584549 2021-01-01 2021-12-31 0001584549 vff:TermLoanVFCEMember 2022-01-01 2022-03-31 0001584549 vff:BDCLoanMember vff:PureSunfarmsMember 2022-01-01 2022-03-31 0001584549 vff:RevolvingOperatingLoanMember 2022-01-01 2022-03-31 0001584549 vff:RevolvingOperatingLoanMember 2021-01-01 2021-12-31 0001584549 vff:TwoThousandTwentyOneNonRevolvingVariableRateTermLoanMember vff:CanadianCreditorMember 2022-03-31 0001584549 vff:TwoThousandTwentyOneNonRevolvingVariableRateTermLoanMember vff:CanadianCreditorMember 2021-12-31 0001584549 vff:RevolvingOperatingLoanMember 2022-03-31 0001584549 vff:RevolvingOperatingLoanMember 2021-12-31 0001584549 vff:RevolvingOperatingLoanMember vff:PureSunfarmsMember 2022-03-31 0001584549 vff:RevolvingOperatingLoanMember vff:PureSunfarmsMember 2021-12-31 0001584549 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-03-31 0001584549 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2021-12-31 iso4217:AUD 0001584549 vff:AtomMember vff:ConvertiblePromissoryNoteMember 2022-02-10 0001584549 vff:AtomMember vff:ConvertiblePromissoryNoteMember 2022-02-10 2022-02-10 0001584549 vff:AtomMember vff:ConvertiblePromissoryNoteMember 2022-03-31 0001584549 vff:VFHempMember 2022-01-01 2022-03-31 0001584549 vff:VFHempMember 2019-03-25 2019-03-25 0001584549 vff:GridLoanAgreementMember 2022-03-31 0001584549 vff:GridLoanAgreementMember 2021-12-31 0001584549 vff:EmployeesMember 2022-01-01 2022-03-31 0001584549 vff:EmployeesMember 2021-01-01 2021-03-31 vff:Segment 0001584549 vff:ProduceBusinessMember 2022-01-01 2022-03-31 0001584549 vff:ProduceBusinessMember 2021-01-01 2021-03-31 0001584549 vff:CannabisCanadaSegmentMember 2022-01-01 2022-03-31 0001584549 vff:CannabisCanadaSegmentMember 2021-01-01 2021-03-31 0001584549 vff:CannabisUnitedStatesSegmentMember 2022-01-01 2022-03-31 0001584549 vff:EnergyBusinessMember 2022-01-01 2022-03-31 0001584549 vff:EnergyBusinessMember 2021-01-01 2021-03-31 0001584549 us-gaap:EmployeeStockOptionMember 2021-12-31 0001584549 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001584549 us-gaap:EmployeeStockOptionMember 2022-03-31 iso4217:CAD xbrli:shares 0001584549 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001584549 vff:PerformanceBasedRestrictedShareUnitMember 2021-12-31 0001584549 vff:PerformanceBasedRestrictedShareUnitMember 2022-01-01 2022-03-31 0001584549 vff:PerformanceBasedRestrictedShareUnitMember 2022-03-31

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 10-Q

 

(Mark One)

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

For the quarterly period ended March 31, 2022 

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

For the transition period from                      to                     

Commission File Number 001-38783

 

VILLAGE FARMS INTERNATIONAL, INC.

(Exact name of Registrant as Specified in its Charter)

 

 

Canada

 

98-1007671

(State or other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

4700-80th Street

Delta, British Columbia Canada

V4K 3N3

(Address of Principal Executive Offices) (Zip Code)

(604) 940-6012

Issuer’s phone number, including area code

N/A

(Former name, former address and former fiscal year, if changed since last report).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Shares, without par value

 

VFF

 

The Nasdaq Stock Market LLC

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.    Yes      No      Not Applicable  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer”, “small reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

  

Smaller reporting company

 

 

 

 

 

Emerging growth company

 

  

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

As of May 6, 2022, 88,561,929 common shares were issued and outstanding.

 



PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

 

TABLE OF CONTENTS

 

 

 

 

Page

PART I - FINANCIAL INFORMATION

 

 

Item 1.

 

Condensed Consolidated Interim Financial Statements (Unaudited)

 

 

 

 

Condensed Consolidated Interim Statements of Financial Position

 

3

 

 

Condensed Consolidated Interim Statements of Loss and Comprehensive Loss

 

4

 

 

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity and Mezzanine Equity

 

5

 

 

Condensed Consolidated Interim Statements of Cash Flows

 

6

 

 

Notes to Condensed Consolidated Interim Financial Statements

 

7

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

16

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

29

Item 4.

 

Controls and Procedures

 

29

 

PART II - OTHER INFORMATION

 

31

Item 1.

 

Legal Proceedings

 

31

Item 1A.

 

Risk Factors

 

31

Item 6.

 

Exhibits

 

32

 

 

 

 

 

 

 

Signatures

 

33

 

 

 

 

 

 

 

 

 

 


PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL INFORMATIONS

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

As used in this Quarterly Report on Form 10-Q, the terms “Village Farms,” “Village Farms International,” the “Company,” “we,” “us,” “our” and similar references refer to Village Farms International, Inc. and our consolidated subsidiaries, and the term “Common Shares” refers to our common shares, no par value. Our financial information is presented in U.S. dollars and all references in this Quarterly Report on Form 10-Q to “$” means U.S. dollars and all references to “C$” means Canadian dollars.

This Quarterly Report on Form 10-Q the following trademarks, trade names and service marks of ours: Village Farms®, Delectable TOV®, From Our House To Your Home®, Mini Sensations®, Sinfully Sweet Campari®, Heavenly Villagio Marzano®, BC Grown Logo®, Texas Grown Logo®, Good for the Earth ®, Village Farms Greenhouse Grown ®, Village Fields®, Pure SunfarmsTM, Pure Sunfarms BC GrownTM, Farm to FlowerTM, No Sun No FlowerTM, Plants and People FirstTM, Pure ProvisionsTM, Rise with the SunTM, The BakeryTM, Purple Sun GodTM, and Pure Sun CBDTM. This report also contains trademarks, trade names and service marks that are owned by other persons or entities.

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is subject to the safe harbor created by those sections. This Quarterly Report on Form 10-Q also contains “forward-looking information” within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information collectively as “forward-looking statements”. Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “try”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q are subject to risks that may include, but are not limited to: our limited operating history, including that of Rose LifeScience Inc. (“Rose”), Balanced Health Botanicals, LLC (“Balanced Health”), Pure Sunfarms, Inc. and our operations of growing hemp in the United States; the legal status of Pure Sunfarms, Rose and Balanced Health cannabis business; risks relating to the integration of Balanced Health and Rose into our cannabis business; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; market position, ability to leverage current business relationships for future business involving hemp and cannabinoids, the ability of Pure Sunfarms and Rose to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g., Pure Sunfarms ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C. 2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; risks relating to conversion of our greenhouses to cannabis production for Pure Sunfarms; risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing COVID-19 pandemic; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Quarterly Report on Form 10-Q are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this Quarterly Report on Form 10-Q. In particular, we caution you that our forward-looking statements are subject to the

1


 

ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events or information as of the date on which the statements are made in this Quarterly Report on Form 10-Q. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

2


 

 

Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars, except share data)

(Unaudited)

 

 

 

March 31, 2022

 

 

December 31, 2021

 

ASSETS

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

34,623

 

 

$

53,417

 

Restricted cash

 

 

6,810

 

 

 

5,250

 

Trade receivables

 

 

35,857

 

 

 

34,360

 

Inventories

 

 

79,611

 

 

 

68,677

 

Note receivable - joint venture

 

 

3,207

 

 

 

 

Other receivables

 

 

582

 

 

 

616

 

Income tax receivable

 

 

3,631

 

 

 

2,430

 

Prepaid expenses and deposits

 

 

10,662

 

 

 

10,209

 

Total current assets

 

 

174,983

 

 

 

174,959

 

Non-current assets

 

 

 

 

 

 

 

 

Property, plant and equipment

 

 

220,616

 

 

 

215,704

 

Note receivable - joint venture

 

 

 

 

 

3,256

 

Investment in minority interests

 

 

2,109

 

 

 

2,109

 

Goodwill

 

 

119,597

 

 

 

117,533

 

Intangibles

 

 

26,512

 

 

 

26,394

 

Deferred tax asset

 

 

18,682

 

 

 

16,766

 

Right-of-use assets

 

 

7,195

 

 

 

7,609

 

Other assets

 

 

6,088

 

 

 

2,581

 

Total assets

 

$

575,782

 

 

$

566,911

 

LIABILITIES

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Line of credit

 

$

9,880

 

 

$

7,760

 

Trade payables

 

 

23,998

 

 

 

22,597

 

Current maturities of long-term debt

 

 

10,585

 

 

 

11,416

 

Accrued sales taxes

 

 

9,235

 

 

 

3,899

 

Accrued loyalty program

 

 

1,728

 

 

 

2,098

 

Accrued liabilities

 

 

15,659

 

 

 

14,168

 

Lease liabilities - current

 

 

872

 

 

 

962

 

Other current liabilities

 

 

1,549

 

 

 

1,413

 

Total current liabilities

 

 

73,506

 

 

 

64,313

 

Non-current liabilities

 

 

 

 

 

 

 

 

Long-term debt

 

 

49,749

 

 

 

50,419

 

Deferred tax liability

 

 

21,257

 

 

 

18,657

 

Lease liabilities - non-current

 

 

6,366

 

 

 

6,711

 

Other liabilities

 

 

2,076

 

 

 

1,973

 

Total liabilities

 

 

152,954

 

 

 

142,073

 

Commitments and contingencies

 

 

 

 

 

 

 

 

MEZZANINE EQUITY

 

 

 

 

 

 

 

 

Redeemable non-controlling interest

 

 

16,271

 

 

 

16,433

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Common stock, no par value per share - unlimited shares authorized; 88,561,929 shares issued and outstanding at March 31, 2022 and 88,233,929 shares issued and outstanding at December 31, 2021.

 

 

365,737

 

 

 

365,561

 

Additional paid in capital

 

 

10,333

 

 

 

9,369

 

Accumulated other comprehensive income

 

 

10,225

 

 

 

6,696

 

Retained earnings

 

 

20,262

 

 

 

26,779

 

Total shareholders’ equity

 

 

406,557

 

 

 

408,405

 

Total liabilities, mezzanine equity and shareholders’ equity

 

$

575,782

 

 

$

566,911

 

 

The accompanying notes are an integral part of these Condensed Consolidated Interim Statements of Financial Position.

3


 

Village Farms International, Inc.

Condensed Consolidated Interim Statements of Loss and Comprehensive Loss

(In thousands of United States dollars, except per share data)

(Unaudited)

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Sales

 

$

70,156

 

 

$

52,396

 

Cost of sales

 

 

(60,252

)

 

 

(50,089

)

Gross margin

 

 

9,904

 

 

 

2,307

 

Selling, general and administrative expenses

 

 

(16,971

)

 

 

(8,092

)

Share-based compensation

 

 

(964

)

 

 

(1,998

)

Interest expense

 

 

(683

)

 

 

(741

)

Interest income

 

 

110

 

 

 

3

 

Foreign exchange gain (loss)

 

 

319

 

 

 

(504

)

Other expense

 

 

(8

)

 

 

(69

)

Loss before taxes and loss from equity method investments

 

 

(8,293

)

 

 

(9,094

)

Recovery of income taxes

 

 

1,666

 

 

 

1,839

 

Loss from equity method investments

 

 

(52

)

 

 

(127

)

Loss including non-controlling interests

 

 

(6,679

)

 

 

(7,382

)

Less: net loss attributable to non-controlling interests, net of tax

 

 

162

 

 

 

 

Net loss attributable to Village Farms International, Inc.

 

$

(6,517

)

 

$

(7,382

)

Basic loss per share attributable to Village Farms International, Inc. shareholders

 

$

(0.07

)

 

$

(0.10

)

Diluted loss per share attributable to Village Farms International, Inc. shareholder

 

$

(0.07

)

 

$

(0.10

)

Weighted average number of common shares used in the

   computation of net loss per share (in thousands):

 

 

 

 

 

 

 

 

Basic

 

 

88,376

 

 

 

76,002

 

Diluted

 

 

88,376

 

 

 

76,002

 

Loss including non-controlling interests

 

$

(6,679

)

 

$

(7,382

)

Less: net loss attributable to non-controlling interests, net of tax

 

 

162

 

 

 

 

Net loss attributable to Village Farms International, Inc.

 

 

(6,517

)

 

 

(7,382

)

Other comprehensive loss:

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

461

 

 

 

1,711

 

Comprehensive loss attributable to Village Farms International, Inc. shareholders

 

$

(6,056

)

 

$

(5,671

)

 

The accompanying notes are an integral part of these Condensed Consolidated Interim Statements of Loss and Comprehensive Loss.

4


 

Village Farms International, Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity and Mezzanine Equity

(In thousands of United States dollars, except for shares outstanding)

(Unaudited)

 

 

 

Three Months Ended March 31, 2022

 

 

 

Number of Common

Shares (in thousands)

 

 

Common Stock

 

 

Additional Paid in

Capital

 

 

Accumulated Other

Comprehensive

(Loss) Income

 

 

Retained Earnings

 

 

Total Shareholders’

Equity

 

 

Mezzanine Equity

 

Balance at January 1, 2022

 

 

88,234

 

 

$

365,561

 

 

$

9,369

 

 

$

6,696

 

 

$

26,779

 

 

$

408,405

 

 

$

16,433

 

Shares issued on exercise of stock options

 

 

328

 

 

 

176

 

 

 

 

 

 

 

 

 

 

 

 

176

 

 

 

 

Share-based compensation

 

 

 

 

 

 

 

 

964

 

 

 

 

 

 

 

 

 

964

 

 

 

 

Cumulative translation adjustment

 

 

 

 

 

 

 

 

 

 

 

3,529

 

 

 

 

 

 

3,529

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,517

)

 

 

(6,517

)

 

 

(162

)

Balance at March 31, 2022

 

 

88,562

 

 

$

365,737

 

 

$

10,333

 

 

$

10,225

 

 

$

20,262

 

 

$

406,557

 

 

$

16,271

 

 

 

 

 

Three Months Ended March 31, 2021

 

 

 

Number of Common

Shares (in thousands)

 

 

Common Stock

 

 

Additional paid in

capital

 

 

Accumulated Other

Comprehensive Loss

 

 

Retained Earnings

 

 

Total Shareholders’

Equity

 

 

Mezzanine Equity

 

Balance at January 1, 2021

 

 

66,912

 

 

$

145,668

 

 

$

17,502

 

 

$

6,255

 

 

$

35,858

 

 

$

205,283

 

 

 

 

Shares issued in public offering, net of issuance costs

 

 

10,887

 

 

 

127,489

 

 

 

 

 

 

 

 

 

 

 

 

127,489

 

 

 

 

Shares issued on exercise of warrant

 

 

3,045

 

 

 

27,743

 

 

 

(10,080

)

 

 

 

 

 

 

 

 

17,663

 

 

 

 

Shares issued on exercise of stock options

 

 

104

 

 

 

192

 

 

 

(67

)

 

 

 

 

 

 

 

 

125

 

 

 

 

Share-based compensation

 

 

243

 

 

 

 

 

 

1,998

 

 

 

 

 

 

 

 

 

1,998

 

 

 

 

Cumulative translation adjustment

 

 

 

 

 

 

 

 

 

 

 

1,711

 

 

 

 

 

 

1,711

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,382

)

 

 

(7,382

)

 

 

 

Balance at March 31, 2021

 

 

81,191

 

 

$

301,092

 

 

$

9,353

 

 

$

7,966

 

 

$

28,476

 

 

$

346,887

 

 

$

 

 

The accompanying notes are an integral part of these Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity and Mezzanine Equity.

5


 

Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

(In thousands of United States dollars)

(Unaudited)

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Cash flows used in operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(6,517

)

 

$

(7,382

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

3,128

 

 

 

3,225

 

Amortization of deferred charges

 

 

66

 

 

 

78

 

Share of loss from joint ventures

 

 

52

 

 

 

127

 

Interest expense

 

 

683

 

 

 

741

 

Interest income

 

 

(110

)

 

 

(3

)

Interest paid on long-term debt

 

 

(747

)

 

 

(851

)

Unrealized foreign exchange gain/loss

 

 

113

 

 

 

 

Non-cash lease expense

 

 

(116

)

 

 

(128

)

Share-based compensation

 

 

964

 

 

 

1,998

 

Deferred income taxes

 

 

(2,062

)

 

 

(2,538

)

Changes in non-cash working capital items

 

 

(5,091

)

 

 

(9,703

)

Net cash used in operating activities

 

 

(9,637

)

 

 

(14,436

)

Cash flows used in investing activities:

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(5,263

)

 

 

(4,706

)

Note receivable

 

 

(3,442

)

 

 

 

Advances to joint ventures

 

 

 

 

 

(5

)

Investment in minority interests

 

 

 

 

 

(500

)

Net cash used in investing activities

 

 

(8,705

)

 

 

(5,211

)

Cash flows provided by financing activities:

 

 

 

 

 

 

 

 

Proceeds from borrowings

 

 

2,120

 

 

 

4,176

 

Repayments on borrowings

 

 

(983

)

 

 

(4,223

)

Proceeds from issuance of common stock and warrants

 

 

 

 

 

135,000

 

Issuance costs

 

 

 

 

 

(7,511

)

Proceeds from exercise of stock options

 

 

176

 

 

 

125

 

Proceeds from exercise of warrants

 

 

 

 

 

17,663

 

Payments on capital lease obligations

 

 

(301

)

 

 

(155

)

Payment of note payable related to acquisition

 

 

 

 

 

(15,498

)

Net cash provided by financing activities

 

 

1,012

 

 

 

129,577

 

Effect of exchange rate changes on cash and cash equivalents

 

 

96

 

 

 

178

 

Net (decrease) increase in cash and cash equivalents

 

 

(17,234

)

 

 

110,108

 

Cash and cash equivalents, beginning of period

 

 

58,667

 

 

 

25,679

 

Cash and cash equivalents, end of period

 

$

41,433

 

 

$

135,787

 

 

The accompanying notes are an integral part of these Condensed Consolidated Interim Statements of Cash Flows.

 

 

 

6


 

 

VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

1

DESCRIPTION OF BUSINESS

Village Farms International, Inc. (“VFF”) and together with its subsidiaries (the “Company”, “we”, “us”, or “our”) is incorporated under the Canada Business Corporation Act. VFF’s principal operating subsidiaries as of March 31, 2022 are Village Farms Canada Limited Partnership, Village Farms, L.P., Pure Sunfarms Corp. (“Pure Sunfarms”), and Balanced Health Botanicals, LLC (“Balanced Health”). VFF also owns a 70% interest in Rose LifeScience Inc. (“Rose”).

The address of the registered office of VFF is 4700 80th Street, Delta, British Columbia, Canada, V4K 3N3.   

The Company’s shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “VFF”.

Village Farms owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. Through its 70% ownership of Rose, the Company has a substantial presence in the Province of Quebec as a cannabis supplier, producer and commercialization expert. The Company’s wholly owned subsidiary, Balance Health, develops and sells high-quality, cannabidiol (“CBD”) based products including ingestible, edible and topical applications. 

2

BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated interim financial statements for the three months ended March 31, 2022 have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited financial statements as of that date. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2021, included in our Annual Report on Form 10-K. The results for the interim periods are not necessarily indicative of the results for the full year.

In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, comprehensive loss, cash flows and the change in equity for the periods presented.

There have been no changes to our significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 1, 2022 that have had a material impact on our condensed consolidated interim financial statements and related notes.

The condensed consolidated interim financial statements reflect the accounts of the Company and its majority-owned and controlled subsidiaries. All intercompany accounts and transactions between our consolidated operations have been eliminated.

 

3

NEW ACCOUNTING PRONOUNCEMENTS

In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. The Company has a line of credit that incorporates LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on the Company’s business or on the overall financial markets. The Company has not adopted any of the optional expedients or exceptions through March 31, 2022 but will continue to evaluate the possible adoption of any such expedients or exceptions.

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

 

 

4

INVENTORIES

Inventories consisted of the following as of:

 

Classification

 

March 31, 2022

 

 

December 31, 2021

 

Cannabis:

 

 

 

 

 

 

 

 

Raw materials

 

$

1,789

 

 

$

2,071

 

Work-in-progress

 

 

8,854

 

 

 

5,056

 

Finished goods

 

 

40,336

 

 

 

32,161

 

Packaging

 

 

7,091

 

 

 

5,877

 

Produce and Energy:

 

 

 

 

 

 

 

 

Crop inventory

 

 

18,688

 

 

 

19,475

 

Purchased produce inventory

 

 

818

 

 

 

2,485

 

Spare parts inventory and packaging

 

 

2,035

 

 

 

1,552

 

Inventory

 

$

79,611

 

 

$

68,677

 

 

 

5

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following:

 

Classification

 

March 31, 2022

 

 

December 31, 2021

 

Land

 

$

14,262

 

 

$

14,095

 

Leasehold and land improvements

 

 

5,231

 

 

 

5,224

 

Buildings

 

 

186,239

 

 

 

184,444

 

Machinery and equipment

 

 

81,036

 

 

 

79,070

 

Construction in progress

 

 

43,442

 

 

 

39,206

 

Less: Accumulated depreciation

 

 

(109,594

)

 

 

(106,335

)

Property, plant and equipment, net

 

$

220,616

 

 

$

215,704

 

 

 

6

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The following table presents the changes in the carrying value of goodwill by reportable segment for the three months ended March 31, 2022:

 

 

 

Cannabis - Canada

 

 

Cannabis - United States

 

 

Total

 

Balance as of December 31, 2021

 

$

57,525

 

 

$

60,008

 

 

$

117,533

 

Foreign currency translation adjustment

 

 

2,064

 

 

 

-

 

 

 

2,064

 

Balance as of March 31, 2022

 

$

59,589

 

 

$

60,008

 

 

$

119,597

 

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

 

 

Intangible Assets

Intangible assets consisted of the following as of:

 

Classification

 

March 31, 2022

 

 

December 31, 2021

 

Licenses

 

$

13,033

 

 

$

12,835

 

Brand and trademarks*

 

 

13,009

 

 

 

12,951

 

Computer Software

 

 

2,028

 

 

 

2,014

 

Other*

 

 

144

 

 

 

144

 

Less: Accumulated amortization

 

 

(1,702

)

 

 

(1,550

)

Intangibles, net

 

$

26,512

 

 

$

26,394

 

    

*Indefinite-lived intangible assets.

 

The expected future amortization expense for definite-lived intangible assets as of March 31, 2022 was as follows:

 

Fiscal period

 

 

 

 

Remainder of 2022

 

$

861

 

2023

 

 

919

 

2024

 

 

786

 

2025

 

 

692

 

2026

 

 

596

 

Thereafter

 

 

9,505

 

Intangibles, net

 

$

13,359

 

 

7

LEASES

The Company leases a parcel of land in Marfa, Texas that one of its greenhouses resides on as well as two distribution centers located in Fort Worth, Texas and Surrey, British Columbia. The Company leases production-related equipment at its greenhouses in Texas and British Columbia. The Company also leases an office building located in Lake Mary, Florida for its corporate headquarters, and office and manufacturing space in Denver, Colorado for Balanced Health’s headquarters and operations. Rose owns land and leases a building for its headquarters and operations in Montreal, Quebec.

The components of lease related expenses are as follows:

 

 

 

Three months ended March 31,

 

 

 

2022

 

 

2021

 

Operating lease expense (a)

 

$

664

 

 

$

622

 

 

 

 

 

 

 

 

 

 

 

 

(a)

Includes short-term lease costs of $153 and $148 for the three months ended March 31, 2022 and 2021, respectively.  

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

Three months ended March 31,

 

 

 

2022

 

 

2021

 

Operating cash flows from operating leases

 

$

116

 

 

$

128

 

Finance cash flows from finance leases

 

$

301

 

 

$

155

 

 

 

 

 

 

 

 

 

 

9


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

 

 

 

 

 

March 31, 2022

 

Weighted average remaining lease term:

 

 

 

 

Operating leases

 

 

6.3

 

Finance leases

 

 

0.3

 

Weighted average discount rate:

 

 

 

 

Operating leases

 

 

8.55

%

Finance leases

 

 

6.25

%

 

Maturities of lease liabilities are as follows:

 

 

 

Operating

leases

 

Remainder of 2022

 

$

1,560

 

2023

 

 

1,900

 

2024

 

 

1,386

 

2025

 

 

1,145

 

2026

 

 

1,166

 

Thereafter

 

 

3,183

 

Undiscounted lease cash flow commitments

 

 

10,340

 

Reconciling impact from discounting